Though the U.S. Food and Drug Administration has approved the first med--Lyrica--to treat fibromyalgia, many doctors still doubt that the chronic pain condition is a real illness. A reporter from The New York Times talks to doctors and patients about fibromyalgia, and he uncovers why some believe approving Lyrica and other medications for the condition may do more harm than good.
Read moreWe've all heard of the placebo effect – when a patient so strongly believes a new treatment will work that they experience improvement... Read more »
The Food and Drug Administration recently approved a third drug indicated for treatment of fibromyalgia. Milnacipran, made by Forest... Read more »
Last week, the United States Food and Drug Administration (FDA) made it official: Lyrica, the trade name of the Pfizer drug pregabalin, was... Read more »
Nutrition-related pain exists. Having talked extensively about how the right and breakfast and dinner foods can help reduce pain and... Read more »
An FDA Advisory Committee recently recommended some changes regarding the use and availability of the very common pain medicine... Read more »
According to new research, only about one third of heart failure patients are adhering to a low-salt diet, and those that are failing to do so often... Read more »
Fibromyalgia is a complex disease that is difficult to treat. But researchers have found some clues to managing the chronic pain condition, and one... Read more »
Dietary fat is often portrayed as a villain – especially when you’re talking about weight control. We always hear that you should avoid fat. And... Read more »
The U.S. Food and Drug Administration (FDA) is warning consumers that an instant coffee product called Magic Powder Coffee that is being sold as a... Read more »
Officials with the U.S. Food and Drug Administration (FDA) say Evamist, a drug used to treat menopause-related hot flashes in women, may be harmful... Read more »